Company profile · Sponsor
CytoMed
CytoMed Therapeutics Ltd
- Pipeline
- 4
- Drugs
- 0
- Patents
- 3
Quick answer
CytoMed (GDTC) is a pharma company. headquartered in 1 COMMONWEALTH LANE, U0, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 3 patents to this profile..
Company facts
Pipeline (4)
Search pipeline →-
Human Umbilical Cord derived MSCs
CytoMed
Lupus Nephritis
1 trial -
Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell
CytoMed
Colorectal Cancer
1 trial -
Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells (CTM-N2D)
CytoMed
Cancer
1 trial -
human Mesenchymal Stem Cell (MSC) infusion therapy
CytoMed
Aging Well
1 trial
Patents (3)
Search patents →Frequently asked questions
What is CytoMed?
CytoMed (GDTC) is a pharma company. headquartered in 1 COMMONWEALTH LANE, U0, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 3 patents to this profile..
What pipeline programs does CytoMed sponsor?
We track 4 ClinicalTrials.gov-linked programs for CytoMed, including Human Umbilical Cord derived MSCs and 3 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does CytoMed company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.